Mobile Navigation

Business & Economics

View Comments

Novo Nordisk invests in new insulin-production plant in China

| By Gerald Ondrey

Novo Nordisk A/S (Bagsvaerd, Denmark; today announced a major investment in a new insulin production plant in Tianjin, China. The plant has been designated Novo Nordisk’s primary production base in the Asia Pacific region and…